SEC Filings for Ligand Pharmaceuticals Incorporated (LGND)

$ 107.81 0.00 (0.00%) Volume: 0 4:00 PM EDT Oct 15, 2019
Filing Type:
Form TypeForm DescriptionPagesDateView
4Statement of changes in beneficial ownership of securities112/29/2017
4Statement of changes in beneficial ownership of securities112/29/2017
4Statement of changes in beneficial ownership of securities112/27/2017
8-KCurrent report pursuant to Section 13 or 15(d)212/26/2017
4Statement of changes in beneficial ownership of securities112/21/2017
4Statement of changes in beneficial ownership of securities111/20/2017
4Statement of changes in beneficial ownership of securities111/20/2017
4Statement of changes in beneficial ownership of securities111/17/2017
4Statement of changes in beneficial ownership of securities111/17/2017
4Statement of changes in beneficial ownership of securities111/17/2017
4Statement of changes in beneficial ownership of securities111/17/2017
8-KCurrent report pursuant to Section 13 or 15(d)11611/14/2017
CT ORDERConfidential treatment order111/13/2017
8-KCurrent report pursuant to Section 13 or 15(d)211/13/2017
10-QGeneral form for quarterly reports under Section 13 or 15(d)7311/09/2017
67891011121314151617181920